About the Event

The 9th Annual Corporate Compliance & Transparency in Life Sciences conference runs November 17 and 18, 2026, in Zurich, Switzerland, organized by Fleming. The organizers frame the 2026 edition around compliance responsibilities expanding across pharma, med-tech, diagnostics and digital health, aiming to help attendees future-proof their compliance programs for 2027.

Audience and Attendees

The conference brings together leaders from pharma, biotech, med-tech, CDMOs, digital health-tech, law firms, patient groups and regulators. Past attendees quoted on the site include representatives from Newport Pharmaceuticals (Ireland), Baxter (Switzerland) and A&D Pharma (Romania).

Programme Structure

The programme is structured around four themes: finalizing 2027 regulatory readiness, staying ahead of European enforcement and guidance with direct insights from EU regulators and national authorities, tackling next-generation compliance challenges, and connecting with Europe's compliance community. The agenda includes a dedicated Speakers section and a downloadable brochure alongside its main sessions.

Main Topics

Sessions cover actionable strategies for adapting to the EU AI Act and EU Data Act across pharma, med-tech and digital health, the practical impact of the updated EFPIA and ABPI Codes of Practice on engagement and disclosure, governance of AI in promotional and operational settings, ethical boundaries in patient support programs and digital HCP engagement, and oversight of connected devices and real-world data partnerships.

Closing Session

The conference runs through its final day, November 18, 2026, in Zurich.

‍